StockData
Boston Scientific Corp logo

Boston Scientific Corp

BSXNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 2, 2026Score 14/3053% below fair value
$43.64+0.61 (+1.42%)

Close on Nov 18, 2026Market cap $63.24BP/E 17.7Yield –

Boston Scientific Revolving Credit Facility Consolidated Leverage Ratio by Quarter

Revolving Credit Facility Consolidated Leverage Ratio — Maximum Covenant Limit (x)

Boston Scientific Revolving Credit Facility Consolidated Leverage Ratio: 3.75 in Q3 2026, down 21.1% from a year earlier. That is the lowest of the 24 quarters on record here.

Latest, Q3 2026
3.75
Period ended Sep 30, 2026
Change on a year earlier
-21.1%
4.75 in Q3 2025
History
24 quarters
Since Q4 2018
Sources
24
Documents cited below

Where the Q3 2026 figure comes from

Source: Form 10-Q — FY2026Q3 (filed 2026-11-02) ↗

Reported in Form 10-K/10-Q Note F Borrowings.

quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedRevolving Credit Facility Consolidated Leverage Ratio — Maximum Covenant Limit (x)Year on yearSource
Q3 2026Sep 30, 20263.75-21.1%Form 10-Q — FY2026Q3 (filed 2026-11-02) ↗
Q2 2026Jun 30, 20264.00-15.8%Form 10-Q — FY2026Q2 (filed 2026-08-03) ↗
Q1 2026Mar 31, 20264.25-10.5%Form 10-Q — FY2026Q1 (filed 2026-05-01) ↗
Q3 2025Sep 30, 20254.75+26.7%Form 10-Q — FY2025Q3 (filed 2025-11-03) ↗
Q2 2025Jun 30, 20254.75+26.7%Form 10-Q — FY2025Q2 (filed 2025-08-01) ↗
Q1 2025Mar 31, 20254.75+26.7%Form 10-Q — FY2025Q1 (filed 2025-05-01) ↗
Q3 2024Sep 30, 20243.750.0%Form 10-Q — FY2024Q3 (filed 2024-11-01) ↗
Q2 2024Jun 30, 20243.750.0%Form 10-Q — FY2024Q2 (filed 2024-08-01) ↗
Q1 2024Mar 31, 20243.750.0%Form 10-Q — FY2024Q1 (filed 2024-05-01) ↗
Q3 2023Sep 30, 20233.750.0%Form 10-Q — FY2023Q3 (filed 2023-11-01) ↗
Q2 2023Jun 30, 20233.750.0%Form 10-Q — FY2023Q2 (filed 2023-08-03) ↗
Q1 2023Mar 31, 20233.750.0%Form 10-Q — FY2023Q1 (filed 2023-05-04) ↗
Q3 2022Sep 30, 20223.75-6.2%Form 10-Q — FY2022Q3 (filed 2022-11-03) ↗
Q2 2022Jun 30, 20223.75-11.8%Form 10-Q — FY2022Q2 (filed 2022-08-04) ↗
Q1 2022Mar 31, 20223.75-16.7%Form 10-Q — FY2022Q1 (filed 2022-05-05) ↗
Q3 2021Sep 30, 20214.00-15.8%Form 10-Q — FY2021Q3 (filed 2021-11-04) ↗

Cite this data

StockData. (2026). Boston Scientific Revolving Credit Facility Consolidated Leverage Ratio, quarterly Q4 2018–Q3 2026 [Data set]. Compiled from Boston Scientific SEC filings and investor materials. https://stockdatahq.com/stocks/bsx/kpis/lev-covenant-max

See every metric in the Boston Scientific KPI table. Data updated Nov 4, 2026.

See a number that looks wrong?